Innolign Biomedical Overview

  • Founded
  • 2013

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Innolign Biomedical General Information


Owner and operator of a biotechnology company intended to assist in therapeutic tissue regeneration. The company's biotechnology services focus on utilizing its novel microfabrication technologies and expertise in tissue engineering to develop high throughput organ-on-chip assessment platforms, enabling pharmaceutical industry to design novel biomaterials as products for promoting therapeutic tissue regeneration.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 3160 Chestnut Street
  • Suite 200
  • Philadelphia, PA 19104
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innolign Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator 01-Dec-2013 Completed Startup
1. Grant 01-Jan-2013 $385K Completed Startup
To view Innolign Biomedical’s complete valuation and funding history, request access »

Innolign Biomedical Executive Team (2)

Name Title Board Seat Contact Info
Christopher Chen Ph.D Principal
You’re viewing 1 of 2 executive team members. Get the full list »

Innolign Biomedical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
UPstart (Philadelphia) Accelerator/Incubator Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Massachusetts Biomedical Initiatives Accelerator/Incubator 000 0000 000000 0
To view Innolign Biomedical’s complete investors history, request access »